| Clinical data | |
|---|---|
| Trade names | Cutivate |
| AHFS/Drugs.com | Monograph |
| Pregnancy category |
|
| Routes of administration |
Intranasal, inhaled, topical cream or ointment |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 0.51% (Intranasal) |
| Protein binding | 91% |
| Metabolism | Intranasal Hepatic (CYP3A4-mediated) |
| Biological half-life | 10 hours |
| Excretion | Renal |
| Identifiers | |
|
|
| Synonyms | 6α,9α-Difluoro-11β,17α-dihydroxy-16α-methyl-21-thia-21-fluoromethylpregna-1,4-dien-3,20-dione |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C22H27F3O4S |
| Molar mass | 444.508 g/mol |
| 3D model (Jmol) | |
|
|
|
|
|
|
|
Fluticasone is a synthetic glucocorticoid. Both the furoate and propanoate esters, fluticasone furoate and fluticasone propionate, are used as topical anti-inflammatories and inhaled corticosteroids.